Fighting cancer using an oncofetal glycosaminoglycan-binding protein from malaria parasites

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Fighting cancer using an oncofetal glycosaminoglycan-binding protein from malaria parasites. / Agerbæk, Mette; Bang-Christensen, Sara; Salanti, Ali.

In: Trends in Parasitology, Vol. 35, No. 3, 2019, p. 178-181.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Agerbæk, M, Bang-Christensen, S & Salanti, A 2019, 'Fighting cancer using an oncofetal glycosaminoglycan-binding protein from malaria parasites', Trends in Parasitology, vol. 35, no. 3, pp. 178-181. https://doi.org/10.1016/j.pt.2018.11.004

APA

Agerbæk, M., Bang-Christensen, S., & Salanti, A. (2019). Fighting cancer using an oncofetal glycosaminoglycan-binding protein from malaria parasites. Trends in Parasitology, 35(3), 178-181. https://doi.org/10.1016/j.pt.2018.11.004

Vancouver

Agerbæk M, Bang-Christensen S, Salanti A. Fighting cancer using an oncofetal glycosaminoglycan-binding protein from malaria parasites. Trends in Parasitology. 2019;35(3):178-181. https://doi.org/10.1016/j.pt.2018.11.004

Author

Agerbæk, Mette ; Bang-Christensen, Sara ; Salanti, Ali. / Fighting cancer using an oncofetal glycosaminoglycan-binding protein from malaria parasites. In: Trends in Parasitology. 2019 ; Vol. 35, No. 3. pp. 178-181.

Bibtex

@article{32775e929cc74d97b8a4866d1a45c3c9,
title = "Fighting cancer using an oncofetal glycosaminoglycan-binding protein from malaria parasites",
abstract = "Malaria research has led to the discovery of oncofetal chondroitin sulfate, which appears to be shared between placental trophoblasts and cancer cells and can be detected by the evolutionary refined malaria protein VAR2CSA. Interestingly, using recombinant VAR2CSA to target oncofetal chondroitin sulfate shows promise for novel cancer diagnostics and therapeutics.",
keywords = "cancer, oncofetal chondroitin sulfate, placental malaria, VAR2CSA",
author = "Mette Agerb{\ae}k and Sara Bang-Christensen and Ali Salanti",
year = "2019",
doi = "10.1016/j.pt.2018.11.004",
language = "English",
volume = "35",
pages = "178--181",
journal = "Trends in Parasitology",
issn = "1471-4922",
publisher = "Elsevier Ltd. * Trends Journals",
number = "3",

}

RIS

TY - JOUR

T1 - Fighting cancer using an oncofetal glycosaminoglycan-binding protein from malaria parasites

AU - Agerbæk, Mette

AU - Bang-Christensen, Sara

AU - Salanti, Ali

PY - 2019

Y1 - 2019

N2 - Malaria research has led to the discovery of oncofetal chondroitin sulfate, which appears to be shared between placental trophoblasts and cancer cells and can be detected by the evolutionary refined malaria protein VAR2CSA. Interestingly, using recombinant VAR2CSA to target oncofetal chondroitin sulfate shows promise for novel cancer diagnostics and therapeutics.

AB - Malaria research has led to the discovery of oncofetal chondroitin sulfate, which appears to be shared between placental trophoblasts and cancer cells and can be detected by the evolutionary refined malaria protein VAR2CSA. Interestingly, using recombinant VAR2CSA to target oncofetal chondroitin sulfate shows promise for novel cancer diagnostics and therapeutics.

KW - cancer

KW - oncofetal chondroitin sulfate

KW - placental malaria

KW - VAR2CSA

U2 - 10.1016/j.pt.2018.11.004

DO - 10.1016/j.pt.2018.11.004

M3 - Journal article

C2 - 30551869

AN - SCOPUS:85058018294

VL - 35

SP - 178

EP - 181

JO - Trends in Parasitology

JF - Trends in Parasitology

SN - 1471-4922

IS - 3

ER -

ID: 212857987